On July 27, 2026, Intuitive Surgical Inc (NASDAQ: ISRG) shares are rebounding amid renewed optimism following Johnson & Johnson’s approval of its Ottava surgical robot. Despite intensifying competition, analysts remain confident in Intuitive Surgical’s market leadership in robotic surgery.
- GF Value™ indicates ISRG is trading at $358.63 versus an intrinsic value of $615.08, implying it is 41.7% undervalued.
- GF Score™ of 91/100 reflects exceptional overall quality, driven by top-tier financial strength, profitability, and growth.
- Insider activity shows moderate selling with no insider purchases over the past three months, totaling approximately $3.1 million in shares sold.
What's Behind the News?
The recent positive movement in ISRG’s stock price follows Johnson & Johnson’s regulatory approval of its Ottava surgical robot, a direct competitor to Intuitive Surgical’s flagship da Vinci system. While this development signals heightened competition in the robotic surgery market, leading analysts at TD Cowen and Piper Sandler have reaffirmed their bullish stance on ISRG. They highlight that competitors will need to accumulate substantial real-world clinical data and develop comprehensive product portfolios to gain broad acceptance, a process expected to take considerable time. This dynamic underscores Intuitive Surgical’s entrenched position and the barriers to entry for rivals.
Intuitive Surgical Inc operates within the Healthcare sector, specifically in the Medical Devices & Instruments industry. The company designs, manufactures, and markets the da Vinci Surgical Systems, which assist minimally invasive surgeries with robotic precision. With a market capitalization of $126.70 billion, ISRG has installed over 10,000 da Vinci systems worldwide, including more than 6,000 in the United States, and continues to expand in emerging markets. Its leadership in robotic-assisted surgery remains a critical competitive advantage amid evolving market conditions.
Is ISRG Overvalued or Undervalued?
According to GuruFocus’ proprietary GF Value™ metric, ISRG’s intrinsic worth stands at $615.08 per share, significantly above its current market price of $358.63. This 41.7% margin of safety suggests that the stock is substantially undervalued relative to its historical trading multiples, business growth, and future earnings potential. Such a valuation gap provides a compelling cushion for investors considering the company’s robust fundamentals and dominant market position.
Examining valuation multiples, ISRG’s trailing twelve months (TTM) price-to-earnings (P/E) ratio is 41.08x, which is considerably lower than its five-year median P/E of 71.83x. This compression in valuation multiples reflects recent market pressures and the competitive landscape but also highlights a potential opportunity given the company’s sustained profitability and growth trajectory. Investors seeking a data-driven valuation perspective can learn more about GF Value™ at GuruFocus GF Value™.
What Does ISRG's GF Score™ Tell Us?
The GF Score™ aggregates multiple dimensions of a company’s financial health, profitability, growth, valuation, and momentum into a single comprehensive rating. ISRG’s outstanding GF Score™ of 91/100 indicates a high-quality business with strong fundamentals. Below is a breakdown of its key sub-ranks:
| Metric | Rating |
|---|---|
| GF Score™ | 91 |
| Financial Strength | 10/10 |
| Profitability | 10/10 |
| Growth | 10/10 |
| Valuation | 4/10 |
| Momentum | 4/10 |
ISRG’s strongest attributes lie in its impeccable financial strength, profitability, and growth metrics, all rated at the highest level. This reflects its robust balance sheet, expanding operating margins, and consistent revenue and earnings growth. However, valuation and momentum scores are more moderate, reflecting the stock’s recent price weakness and competitive pressures. Overall, the GF Score™ confirms ISRG as a fundamentally sound company with attractive long-term prospects. For more details, visit the ISRG stock page.
What Are Insiders Doing with ISRG Stock?
Insider activity over the past three months reveals no insider purchases but eight insider selling transactions totaling approximately $3.1 million in shares sold. This trend of insider selling, without offsetting buying, may warrant attention as it contrasts with the company’s strong fundamentals. Over the past year, insiders have sold shares valued at over $107 million, with no reported insider buying. Such activity can sometimes signal management’s cautious stance on near-term stock performance, despite the company’s solid financial footing.
What This Means for Investors
Intuitive Surgical’s significant undervaluation relative to its GF Value™ of $615.08, combined with a stellar GF Score™ of 91, underscores a compelling margin of safety for investors focused on quality and growth. While the stock’s valuation and momentum ranks are subdued, likely reflecting competitive headwinds and recent price declines, the company’s dominant market position, strong profitability, and financial strength provide a solid foundation. The insider selling activity, however, introduces a note of caution, suggesting investors should monitor developments closely. Those interested in a deeper dive into ISRG’s fundamentals and valuation can explore the ISRG stock page or utilize the GuruFocus Stock Screener to identify similar opportunities.
Frequently Asked Questions
What is ISRG's GF Score™?
ISRG’s GF Score™ is 91 out of 100, indicating a high-quality company with excellent financial strength, profitability, and growth metrics, though with moderate valuation and momentum scores.
Is ISRG overvalued or undervalued?
Based on GuruFocus’ GF Value™, ISRG is 41.7% undervalued, trading at $358.63 while its intrinsic value is estimated at $615.08, suggesting a significant margin of safety for investors.
What is ISRG's P/E ratio compared to historical?
ISRG’s current trailing P/E ratio is 41.08x, which is substantially below its five-year median P/E of 71.83x, indicating the stock is trading at a discount relative to its historical earnings multiple.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
